Table 1 Patient characteristics
From: Diversity of immunization strongly impacts SARS-CoV-2 antibody function surrogates
Unvaccinated Convalescent | Vaccinated Convalescent | Vaccinated Naïve | BTI | ||||||
|---|---|---|---|---|---|---|---|---|---|
Mild WT | Severe WT | WT/ChAdOx | WT/BNT | WT/BNT (2) | ChAdOx/BNT | BNT (2) | BNT (3) | BNT/BA.1 | |
n | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 |
Female n (%) | 15 (75) | 10 (50,0) | 13 (65,0) | 16 (80,0) | 15 (75) | 10 (50.0) | 15 (75) | 15 (75,0) | 17 (80,0) |
Age at blood sampling (years). median (IQR) | 28,5 (25,0–33,5) | 53,0 (42,5–65,8) | 32,0 (26,5–35,3) | 37,5 (32,5–40,3) | 31,0 (26,0–38.75) | 30,5 (28,8–32,3) | 34,5 (30,8–39,3) | 50,5 (37,3–60,0) | 45,5 (28,0–54,3) |
Body mass index. median (IQR) | 22,4 (20,5–24,1) | 26,2 (23,8–29,1) | 23,4 (21,2–26,0) | 23,6 (20,7-25,9) | 22,3 (19,1–24,9) | 22,5 (20,8–24,1) | 24,2 (21,5–29,2) | 24,1 (21,8–27,0) | 22,3 (21,5–24,3) |
Presence of comorbidity, * n (%) | 6 (30,0) | NA | 2 (10,0) | 7 (35,0) | 6 (30,0) | 3 (15,0) | 7 (35.0) | 9 (45,0) | 5 (20,0) |
Immunization to blood sample interval (days). median (IQR) | 191,5 (183,5–196,5) | 292 (268,0–306,3) | 218 (197,5–243,0) | 185 (174,5–211,5) | 224,5 (208,8–241.5) | 183,5 (175,0–190,0) | 190 (163,0–196,3) | 184 (179,0-210,0) | 190 (175,5–196,5) |
# of vaccinations | NA | NA | 1 | 1 | 2 | 2 | 2 | 3 | 2 (n = 7) 3 (n = 13) |
